Alzheimer’s disease is one of the most common brain conditions in the world, especially among older adults. It slowly affects ...

Boston scientists say a routine blood draw might spot the earliest changes of Alzheimer’s long before the brain lights up on high-tech scans, potentially shifting how and when the disease is caught.

Plasma pTau217 may detect initial buildup of AD-related brain changes before they can be detected by current ‘gold standard’ ...

Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to identify the earliest signs of Alzheimer’s disease in cognitively healthy adults.

A new study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, can predict the progression of amyloid ...

The secret might be hidden in our blood. Boston researchers in a new study have found that a blood test can predict Alzheimer’s disease progression years before symptoms or brain scan changes. The ...

Manhasset-based North Shore University Hospital (NSUH), which is part of Northwell Health, is incorporating a new tool that is designed to speed the assessment of traumatic brain injuries (TBI), ...